{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:12:00Z","timestamp":1748319120894,"version":"3.41.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1023\/a:1007025423232","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:59:48Z","timestamp":1040547588000},"page":"533-545","source":"Crossref","is-referenced-by-count":3,"title":["Effect of the COX-2 Selective Inhibitor L-745,337 on Inflammation and Organ Prostaglandin E2 (PGE2) Levels in Adjuvant Arthritic Rats"],"prefix":"10.1007","volume":"24","author":[{"given":"\u00c0ngels","family":"Turull","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep","family":"Queralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"226748_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.1996.tb00144.x","volume":"10","author":"M. Pairet","year":"1996","unstructured":"PAIRET, M., and G. ENGELHARDT. 1996. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam. Clin. Pharmacol.\n10:1-15.","journal-title":"Fundam. Clin. Pharmacol."},{"key":"226748_CR2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev.pharmtox.38.1.97","volume":"38","author":"J. R. Vane","year":"1998","unstructured":"VANE, J. R., Y. S. BAKHLE, and R. M. BOTTING. 1998. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol.\n38:97-120.","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"226748_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3181\/00379727-91-22179","volume":"91","author":"C. M. Pearson","year":"1996","unstructured":"PEARSON, C. M. 1996. Development of arthritis, periarthritis and periostitis in rats given adjuvant. Proc. Exp. Biol. Med.\n91:95-101.","journal-title":"Proc. Exp. Biol. Med."},{"key":"226748_CR4","first-page":"199","volume":"2","author":"R. T. Owen","year":"1980","unstructured":"OWEN, R. T. 1980. Adjuvant-induced polyarthritis. An overview. Meth. Find. Exp. Clin. Pharmacol.\n2:199-204.","journal-title":"Meth. Find. Exp. Clin. Pharmacol."},{"key":"226748_CR5","first-page":"1","volume-title":"Anti-Rheumatic Drugs","author":"M. E. J. Billingham","year":"1990","unstructured":"BILLINGHAM, M. E. J. 1990. Models of arthritis and the search for anti-arthritic drugs. In Orme MCLE, eds. Anti-Rheumatic Drugs. Pergamon Press Inc. New York. 1-47."},{"key":"226748_CR6","first-page":"42","volume":"265","author":"E. Brahm","year":"1991","unstructured":"BRAHM, E. 1991. Animal models of rheumatoid arthritis. Clues to etiology and treatment. Clin. Orthop.\n265:42-53.","journal-title":"Clin. Orthop."},{"key":"226748_CR7","first-page":"173","volume":"33","author":"M. Melli","year":"1998","unstructured":"MELLI, M. 1998. Assessment of plasma leukotriene and prostaglandin levels during adjuvant arthritis and kaolin-induced paw oedema in rats. Prostag. Leukotr. Ess.\n33:173-178.","journal-title":"Prostag. Leukotr. Ess."},{"key":"226748_CR8","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0090-6980(95)00137-9","volume":"50","author":"D. O. Stichtenoth","year":"1995","unstructured":"STICHTENOTH, D. O., N. SELVE, D. TSIKAS, F. M. GUTZKI, and J. C. FR \u00d6LICH. 1995. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. Prostaglandins\n50:331-340.","journal-title":"Prostaglandins"},{"key":"226748_CR9","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI118717","volume":"97","author":"G. D. Anderson","year":"1996","unstructured":"ANDERSON, G. D., S. D. HAUSER, K. L. MCGARITY, M. E. BREMER, P. C. ISACKSON, and S. A. GREGORY. 1996. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rats adjuvant arthritis. J. Clin. Invest.\n97:2672-2679.","journal-title":"J. Clin. Invest."},{"key":"226748_CR10","first-page":"61","volume":"2","author":"A. Robert","year":"1984","unstructured":"ROBERT, A. 1984. Prostaglandins: effects on the gastrointestinal tract. Clin. Physiol. Biochem.\n2:61-69.","journal-title":"Clin. Physiol. Biochem."},{"key":"226748_CR11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF00398975","volume":"27","author":"S. Iseki","year":"1965","unstructured":"ISEKI, S. 1965. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem. J.\n27:323-328.","journal-title":"Histochem. J."},{"key":"226748_CR12","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0014-5793(93)80263-T","volume":"330","author":"G. P. O'Neill","year":"1993","unstructured":"O'NEILL, G. P., and A. W. FORD-HUTCHINSON. 1993. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett.\n330:156-160.","journal-title":"FEBS Lett."},{"key":"226748_CR13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1053\/gast.1997.v112.pm9024292","volume":"112","author":"H. Mizuno","year":"1997","unstructured":"MIZUNO, H., C. SAKAMOTO, K. MATSUDA, K. WADA, T. UCHIDA, H. NOGUCHI, T. AKAMATSU, and M. KASUGA. 1997. Induction of cyclooxygenase-2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology\n112:387-397.","journal-title":"Gastroenterology"},{"key":"226748_CR14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/S0022-3565(24)37734-1","volume":"286","author":"J. Shigeta","year":"1998","unstructured":"SHIGETA, J., S. TAKAHASHI, and S. OKABE. 1998. Role of cyclooxygenase-2 in the healing of gastric ulcers in rats. J. Pharmacol. Exp. Ther.\n286:1383-1390.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"226748_CR15","first-page":"G1137","volume":"275","author":"S. Takahashi","year":"1998","unstructured":"TAKAHASHI, S., J. SHIGETA, H. INOUE, T. TANABE, and S. OKABE. 1998. Localization of cyclooxygenase-2 and regulation of its mRNA expression in gastric ulcers in rats. Am. J. Physiol.\n275:G1137-G1145.","journal-title":"Am. J. Physiol."},{"key":"226748_CR16","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1023\/A:1018846912032","volume":"43","author":"H. Ukawa","year":"1998","unstructured":"UKAWA, H., H. YAMAKUNI, S. KATO, and K. TAKEUCHI. 1998. Effects of cyclooxygenase-2 selective and nitric-oxyde-releasing nonsteroidal anti-inflammatory drugs on mucosal ulcerogenic and healing responses of the stomach. Dig. Dis. Sci.\n43:2003-2011.","journal-title":"Dig. Dis. Sci."},{"key":"226748_CR17","first-page":"516","volume":"43","author":"B. F. Palmer","year":"1995","unstructured":"PALMER, B. F. 1995. Renal complications associated with use of nonsteroidal anti-inflammatory agents. J. Invest. Med.\n43:516-532.","journal-title":"J. Invest. Med."},{"key":"226748_CR18","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI117620","volume":"94","author":"R. C. Harris","year":"1994","unstructured":"HARRIS, R. C., J. A. MCKANNA, J. AKAI, H. R. JACOBSEN, R. N. DUBOIS, and M. D. BREYER. 1994. Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J. Clin. Invest.\n94:2504-2510.","journal-title":"J. Clin. Invest."},{"key":"226748_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/bj3130617","volume":"313","author":"R. M. N\u00fcSING","year":"1996","unstructured":"N\u00fcSING, R. M., T. KLEIN, J. PFEILSCHIFTER, and V. ULLRICH. 1996. Effect of cyclic AMP and prostaglandin E2 on the induction of nitric oxide and-and prostanoid-forming pathways on cultured mesangial cells. Biochem. J.\n313:617-623.","journal-title":"Biochem. J."},{"key":"226748_CR20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1517\/13543784.3.12.1323","volume":"3","author":"R. Aslanian","year":"1994","unstructured":"ASLANIAN, R., N. I. CARRUTHERS, and J. J. KAMINSKI. 1994. Cyclooxygenase-2: a novel target for therapeutic intervention. Exp. Opin. Invest. Drugs\n3:1323-1325.","journal-title":"Exp. Opin. Invest. Drugs"},{"key":"226748_CR21","doi-asserted-by":"crossref","first-page":"4897","DOI":"10.1021\/jm00025a007","volume":"38","author":"C. S. Li","year":"1995","unstructured":"LI, C. S., W. C. BLACK, C. C. CHAN, A. W. FORD-HUTCHINSON, J. Y. GAUTHIER, R. GORDON, D. GUAY, S. KARGMAN, C. K. LAU, J. MANCINI, N. OUIMET, P. ROY, P. VICKERS, E. WONG, R. N. YOUNG, R. ZAMBONI, and P. PRASIT. 1995. Cyclooxygenase-2 inhibitors. Synthesis and pharmacological activities of 5-methanesulfonamido-1-indanone derivatives. J. Med. Chem.\n38:4897-4905.","journal-title":"J. Med. Chem."},{"key":"226748_CR22","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1111\/j.1476-5381.1995.tb15091.x","volume":"116","author":"M. R. Panara","year":"1995","unstructured":"PANARA, M. R., A. GRECO, G. SANTINI, M. G. SCIULLI, M. T. ROTONDO, R. PADOVANO, M. GIAMBERARDINO, F. CIPOLLONE, F. CUCCURULLO, C. PATRONO, and P. PATRIGNANI. 1995. Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothio-phenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prostaglandin endoperoxide synthases. British J. Pharmacol.\n116:2429-2434.","journal-title":"British J. Pharmacol."},{"key":"226748_CR23","first-page":"623","volume":"48","author":"P. Patrignani","year":"1997","unstructured":"PATRIGNANI, P., M. R. PANARA, M. G. SCIULLI, G. SANTINI, G. RENDA, and C. PATRONO. 1997. Differential inhibition of human prostaglandin endoperoxide synthase-1 and-2 by nonsteroidal anti-inflammatory drugs. J. Physiol. Pharmacol.\n48:623-631.","journal-title":"J. Physiol. Pharmacol."},{"key":"226748_CR24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/sj.bjp.0701076","volume":"121","author":"D. Riendeau","year":"1997","unstructured":"RIENDEAU, D., M. D. PERCIVAL, S. BOYCE, C. BRIDEAU, S. CHARLESON, W. CROMLISH, D. EITHER, J. EVANS, J. P. FALGUEYRET, A. W. FORD-HUTCHINSON, R. GORDON, G. GREIG, M. GRESSER, J. GUAY, S. KARGMAN, S. LEGER, J. A. MANCINI, G. O'NEILL, M. OUELLET, I. W. RODGER, M. THERIEN, Z. WANG, J. K. WEBB, E. WONG, and C.-C. CHANG. 1997. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor. Br. J. Pharmacol.\n121:105-117.","journal-title":"Br. J. Pharmacol."},{"key":"226748_CR25","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/sj.bjp.0702518","volume":"126","author":"F. Giuliano","year":"1999","unstructured":"GIULIANO, F., and T. D. WARNER. 1999. Ex vivo assay to determine the cyclooxygenase selectivity of non-steroidal anti-inflammatory drugs. Br. J. Pharmacol.\n126:1824-1830.","journal-title":"Br. J. Pharmacol."},{"key":"226748_CR26","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/BF02265118","volume":"45","author":"C. Brideau","year":"1996","unstructured":"BRIDEAU, C., S. KARGMAN, S. LIU, A. L. DALLOB, E. W. EHRICH, I. W. RODGER, and C. C. CHAN. 1996. A human whole blood assay for clinical evaluation of biochemical efficacy of cycloogenase inhibitors. Inflamm. Res.\n45:68-74.","journal-title":"Inflamm. Res."},{"key":"226748_CR27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0022-3565(25)10713-1","volume":"274","author":"C. C. Chan","year":"1995","unstructured":"CHAN, C. C., S. BOYCE, C. BRIDEAU, A. W. FORD-HUTCHINSON, R. GORDON, D. GUAY, R. G. HILL, C. S. LI, J. MANCINI, M. PENNETON, P. PRASIT, R. RASORI, D. RIENDEAU, P. ROY, P. TAGARI, P. VICKERS, E. WONG, and I. W. RODGER. 1995. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach. J. Pharmacol. Exp. Ther.\n274:1531-1537.","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"226748_CR28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0016-5085(98)70370-1","volume":"114","author":"J. L. Wallace","year":"1998","unstructured":"WALLACE, J. L., A. BAK, W. MCKNIGHT, S. ASFAHA, K. A. SHARKEY, and W. K. MACNAUGHTON. 1998. Cyclooxygenase-1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity. Gastroenterol.\n114:101-109.","journal-title":"Gastroenterol."},{"key":"226748_CR29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(24)34934-1","volume":"290","author":"C. C. Chan","year":"1999","unstructured":"CHAN, C. C., S. BOYCE, C. BRIDEAU, S. CHARLESON, W. CROMLISH, D. ETHIER, J. EVANS, A. W. FORD-HUTCHINSON, M. J. FORREST, J. Y. GAUTHIER, R. GORDON, M. GRESSER, J. GUAY, S. KARGMAN, B. KENNEDY, Y. LEBLANC, S. LEGER, J. MANCINI, G. P. O'-NEILL, M. OUELLET, D. PATRICK, M. D. PERCIVAL, H. PERRIER, P. PRASIT, I. RODGER, P. TAGARI, M. THERIEN, P. VICKERS, D. VISCO, Z. WANG, J. WEBB, E. WONG, L. J. XU, R. N. YOUNG, R. ZAMBORI, and D. RIENDEAU. 1999. Rofecoxib [Vioxx, MK-0966; 4-(4?-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone] a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J. Pharmacol. Expth. Ther.\n290:551-560.","journal-title":"J. Pharmacol. Expth. Ther."},{"key":"226748_CR30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1517\/13543776.6.1.41","volume":"6","author":"G. C. I. Chiou","year":"1996","unstructured":"CHIOU, G. C. I., and S. L. X. LIU. 1996. Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis. Novel, non-traditional, non-steroidal, anti-inflammatory agents. Exp. Opin. Ther. Patents.\n6:41-56.","journal-title":"Exp. Opin. Ther. Patents."},{"key":"226748_CR31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0304-3959(88)90300-4","volume":"33","author":"M. Castell","year":"1988","unstructured":"CASTELL, M., A. DIETZ, T. CAMBRAS, M. RIBOT, C. CASTELLOTE, and J. QUERALT. 1988. Alterations of motor activity circadian rhythm in rats with adjuvant arthritis. Pain.\n33:379-383.","journal-title":"Pain"},{"key":"226748_CR32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/ard.37.3.218","volume":"37","author":"M. J. Parnham","year":"1978","unstructured":"PARNHAM, M. J., I. L. BONTA, and M. J. ADOLFS. 1978. Cyclic AMP and prostaglandin E in perfussates of rat hind paws during the development of adjuvant arthritis. Ann. Rheum. Dis.\n37:218-224.","journal-title":"Ann. Rheum. Dis."},{"key":"226748_CR33","first-page":"214","volume":"125","author":"Y. Floman","year":"1977","unstructured":"FLOMAN, Y., E. OKON, and U. ZOR. 1977. The role of prostaglandins in experimental arthritis in the rat. Clin. Orthop.\n125:214-220.","journal-title":"Clin. Orthop."},{"key":"226748_CR34","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/BF01972377","volume":"15","author":"R. Schleyerbach","year":"1984","unstructured":"SCHLEYERBACH, R., and H. WEDDE. 1984. Alterations in the gastro-intestinal functions during the development of adjuvant disease in rats. Agents Actions.\n15:392-397.","journal-title":"Agents Actions."},{"key":"226748_CR35","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0016-5085(95)90576-6","volume":"109","author":"D. M. Mccafferty","year":"1995","unstructured":"MCCAFFERTY, D. M., D. N. GRANGER, and J. L. WALLACE. 1995. Indomethacin-induced gastric injury and leukocyte adherence in arthritic versus healthy rats. Gastroenterology\n109:1173-1180.","journal-title":"Gastroenterology"},{"key":"226748_CR36","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF00333430","volume":"56","author":"C. N. Aguwa","year":"1985","unstructured":"AGUWA, C. N. 1985. Incidence of gastric ulcers by indomethacin and piroxicam in rats. Arch. Toxicol.\n56:212-213.","journal-title":"Arch. Toxicol."},{"key":"226748_CR37","first-page":"1115","volume":"42","author":"A. Ohara","year":"1992","unstructured":"OHARA, A., S. SUGIYAMA, H. HOSHINO, E. HAMAJIMA, H. GOTO, Y. TSUKAMOTO, and T. OZAWA. 1992. Reduction of adverse effects of indomethacin by anti-allergic drugs in rat stomachs. Armeimittel-Forschung\n42:1115-1118.","journal-title":"Armeimittel-Forschung"},{"key":"226748_CR38","first-page":"501","volume":"15","author":"I. Wiesenberg-BOETTCHER","year":"1989","unstructured":"WIESENBERG-BOETTCHER, I., A. SCHWEIZER, J. R. GREEN, K. MUELLER, F. MAERKI, and J. PFEILSCHIFTER. 1989. The pharmacological profile of CGP 28,238, a novel highly potent antiinflammatory compound. Drugs Exptl. Clin. Res.\n15:501-509.","journal-title":"Drugs Exptl. Clin. Res."},{"key":"226748_CR39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1476-5381.1979.tb16103.x","volume":"67","author":"P. Del Soldato","year":"1979","unstructured":"DEL SOLDATO, P., A. MELI, and G. VOLTERRA. 1979. Influence of fasting and cimetidine on relationship between ulcerogenic and anti-inflammatory properties of indomethacin. Br. J. Pharmacol.\n67:33-37.","journal-title":"Br. J. Pharmacol."},{"key":"226748_CR40","first-page":"72","volume":"39","author":"A. I. Vengerovskii","year":"1977","unstructured":"VENGEROVSKII, A. I., A. S. SARATIKOV, and N. M. THIKHONOVA. 1977. Structural and metabolic disorders in the heart, liver and kidneys in adjuvant disease. Arkh. Patol.\n39:72-77.","journal-title":"Arkh. Patol."},{"key":"226748_CR41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/PL00020024","volume":"190","author":"M. A. Franch","year":"1990","unstructured":"FRANCH, M. A., J. J. MORENO, M. CASTELL, and J. QUERALT. 1990. Urinary N-acetyl-b-Dglucosaminidase as a marker of renal injury in adjuvant arthritis. Res. Exp. Med.\n190:213-218.","journal-title":"Res. Exp. Med."},{"key":"226748_CR42","first-page":"F481","volume":"43","author":"T. Yang","year":"1998","unstructured":"YANG, T., I. SINGH, H. PHAM, D. SUN, A. SMART, J. B. SCHNERMANN, and J. P. BRIGGS. 1998. Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am. J. Physiol.\n43:F481-F489.","journal-title":"Am. J. Physiol."},{"key":"226748_CR43","first-page":"86","volume":"63","author":"I. N. Pribytkov","year":"1991","unstructured":"PRIBYTKOV, I. N., N. I. KORSHUNOV, and B. N. FRIZEN. 1991. Prostaglandins in the blood serum of patients with rheumatoid arthritis. Terapevticheskii Arkhv.\n63:86-90.","journal-title":"Terapevticheskii Arkhv."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007025423232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007025423232\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007025423232.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:51:09Z","timestamp":1748263869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007025423232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["226748"],"URL":"https:\/\/doi.org\/10.1023\/a:1007025423232","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"type":"print","value":"0360-3997"},{"type":"electronic","value":"1573-2576"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}